Cancer Gene Therapy Global Market Report 2025

Name: Cancer Gene Therapy Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Download Sample Buy Report

Global Cancer Gene Therapy Market Report 2025

Cancer Gene Therapy Global Market Report 2025 - By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer), By Indication (Large B-Cell Lymphoma, Multiple Myeloma, Acute Lymphoblastic Leukemia (ALL), Melanoma (lesions), Other Indications), By Vector Type (Lentivirus, RetroVirus And Gamma RetroVirus, Adeno-Associated Virus (AAV), Modified Herpes Simplex Virus, Adenovirus, Other Vector Types), By End-User (Hospitals, Research Institutes, Biopharma Companies, Diagnostic centers, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Cancer Gene Therapy Global Market Report 2025

Report Price : $4490.00 | Pages : 250 | Published : September 2025 | Delivery Time: 2-3 business days | Format :

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Regional Data

FAQs

Cancer Gene Therapy Global Market Report 2025

Cancer Gene Therapy Market Overview

• Cancer Gene Therapy market size has reached to $3.61 billion in 2024

• Expected to grow to $7.67 billion in 2029 at a compound annual growth rate (CAGR) of 16.2

• Growth Driver: Rising Cancer Incidence Fueling The Growth Of The Market Due To Increasing Life Expectancy

• Market Trend: Breakthrough In Affordable Personalized Cancer Treatment Through Advanced Cell Therapy

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cancer Gene Therapy Market?

Cancer gene therapy is a treatment that uses special genes to help fight cancer. It works by changing or adding genes in a person’s cells to stop the cancer from growing. This can help the body attack the cancer more effectively. The goal is to treat the disease in a more targeted and less harmful way than traditional methods.

The main types of cancer gene therapies include gene-induced immunotherapy, oncolytic virotherapy, and gene transfer. Gene-induced immunotherapy uses genes to enhance the body's immune system so it can better identify and eliminate cancer cells. It is used for various indications such as large B-cell lymphoma, multiple myeloma, acute lymphoblastic leukemia (ALL), melanoma, and others, and uses different vector types including lentivirus, retrovirus and gamma retrovirus, adeno-associated virus (AAV), modified herpes simplex virus, adenovirus, and others. It is used by several end-users, including hospitals, research institutes, biopharma companies, diagnostic centers, and others.

Cancer Gene Therapy Market Size and growth rate 2025 to 2029: Graph

What Is The Cancer Gene Therapy Market Size 2025 And Growth Rate?

What Is The Cancer Gene Therapy Market Growth Forecast?

The cancer gene therapy market size is expected to see rapid growth in the next few years. It will grow to $7.67 billion in 2029 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to rising focus on non-viral delivery systems, increasing availability of companion diagnostics, growing interest in off-the-shelf allogeneic cell therapies, rising expansion of contract development & manufacturing organizations (CDMOs), and advancing synthetic biology enabling customizable gene circuits. Major trends in the forecast period include advancement in non-viral gene delivery platforms, advanced manufacturing automation for gene therapy production, development of synthetic promoters for cancer-specific expression, innovation in intratumoral gene therapy administration, and development of multiplexed gene modulation strategies.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Cancer Gene Therapy Market Segmented?

1) By Therapy: Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer

2) By Indication: Large B-Cell Lymphoma, Multiple Myeloma, Acute Lymphoblastic Leukemia (ALL), Melanoma (lesions), Other Indications

3) By Vector Type: Lentivirus, RetroVirus And Gamma RetroVirus, Adeno-Associated Virus (AAV), Modified Herpes Simplex Virus, Adenovirus, Other Vector Types

4) By End-User: Hospitals, Research Institutes, Biopharma Companies, Diagnostic centers, Other End Users

Subsegments:

1) By Gene Induced Immunotherapy: CAR-T Cell Therapy, TCR (T-Cell Receptor) Therapy, Tumor-Infiltrating Lymphocyte (TIL) Therapy, Dendritic Cell-Based Gene Therapy, NK Cell Gene Therapy

2) By Oncolytic Virotherapy: Adenoviruses, Herpes Simplex Virus (HSV), Reovirus, Vaccinia Virus, Newcastle Disease Virus (NDV)

3) By Gene Transfer: Viral Gene Transfer, Non-Viral Gene Transfer

What Is Driving The Cancer Gene Therapy Market? Rising Cancer Incidence Fueling The Growth Of The Market Due To Increasing Life Expectancy

The increasing cancer incidence is expected to propel the growth of the cancer gene therapy market going forward. Cancer is a disease characterized by the uncontrolled multiplication of abnormal cells that can invade and spread to other parts of the body, arising in various tissues and organs and classified based on the cell or tissue type from which it originates. Cancer cases are increasing due to rising life expectancy, as the risk of developing cancer grows with age. Cancer gene therapy treats cancer by modifying or replacing faulty genes to stop cancer cell growth or enhance the immune system's ability to destroy them. For instance, in August 2024, Macmillan Cancer Support, a UK-based organization, reported that more than 3 million people in the UK are living with cancer. This figure is projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing cancer incidence is driving the growth of the cancer gene therapy industry.

Who Are The Major Players In The Global Cancer Gene Therapy Market?

Major companies operating in the cancer gene therapy market are Bristol Myers Company, Novartis AG, GSK plc., Gilead Sciences Inc., Amgen Inc., Orchard Therapeutics Plc, Biogen Inc., Sarepta Therapeutics Inc., AGC Biologics, Adaptimmune Limited, Sibiono, Elevate Bio Inc., Bluebird Bio Inc., Uniqure N.V., Shanghai Sunway Biotech Co. Ltd., Anges Inc., Gensight Biologics, Genelux Corporation, Cellectis, and Abeona Therapeutics Inc.

What Are The Key Trends Of The Global Cancer Gene Therapy Market? Breakthrough In Affordable Personalized Cancer Treatment Through Advanced Cell Therapy

Major companies operating in the cancer gene therapy market are focusing on developing advanced therapies, such as CAR-T cell therapy, to enhance treatment precision, improve patient outcomes, and target cancer cells more effectively while minimizing damage to healthy tissues. CAR-T therapy is an advanced immunotherapy where a patient’s immune cells are engineered to better detect and destroy cancer cells by adding special receptors to them. For instance, in April 2024, ImmunoACT, an India-based biotechnology company, launched NexCAR19 (actalycabtagene autoleucel), the country's first indigenously developed CAR-T cell therapy for cancer. Specifically designed to treat B-cell lymphomas and leukemias, NexCAR19 works by reprogramming a patient's own T cells to identify and destroy cancer cells. Based on advanced chimeric antigen receptor (CAR) technology, the therapy is locally manufactured, making it more affordable and accessible than imported alternatives. This launch marks a major milestone in India's entry into the global cancer gene therapy space, highlighting significant progress in domestic innovation and personalized cancer treatment.

What Are Latest Mergers And Acquisitions In The Cancer Gene Therapy Market? Astrazeneca Acquires Esobiotec To Bolster Cell Therapy Pipeline

In May 2025, AstraZeneca plc, a UK-based biopharmaceutical company, acquired EsoBiotec B.V. for an undisclosed amount. With this acquisition, it aims to strengthen its cell therapy capabilities, accelerating its ambition to develop next-generation treatments in oncology and immune-mediated diseases. EsoBiotec B.V. is a Switzerland-based biotechnology company that specializes in cancer gene therapies.

What Is The Regional Outlook For The Global Cancer Gene Therapy Market?

North America was the largest region in the cancer gene therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cancer Gene Therapy Market?

The cancer gene therapy market consists of revenues earned by entities by providing services such as gene delivery services, clinical trial services, gene editing, and cell-based therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The cancer gene therapy market also includes sales of gene therapy drugs, viral vectors, non-viral delivery systems, and plasmids. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cancer Gene Therapy Industry?

The cancer gene therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cancer gene therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author: Abdul Wasay

Cancer Gene Therapy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$4.21 billion
Revenue Forecast In 2034	$7.67 billion
Growth Rate	CAGR of 16.2% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Therapy, Indication, Vector Type, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Bristol Myers Company, Novartis AG, GSK plc., Gilead Sciences Inc., Amgen Inc., Orchard Therapeutics Plc, Biogen Inc., Sarepta Therapeutics Inc., AGC Biologics, Adaptimmune Limited, Sibiono, Elevate Bio Inc., Bluebird Bio Inc., Uniqure N.V., Shanghai Sunway Biotech Co. Ltd., Anges Inc., Gensight Biologics, Genelux Corporation, Cellectis, and Abeona Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Cancer Gene Therapy Market Characteristics

3. Cancer Gene Therapy Market Trends And Strategies

4. Cancer Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cancer Gene Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Cancer Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cancer Gene Therapy Market Growth Rate Analysis

5.4. Global Cancer Gene Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cancer Gene Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cancer Gene Therapy Total Addressable Market (TAM)

6. Cancer Gene Therapy Market Segmentation

6.1. Global Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Induced Immunotherapy

Oncolytic Virotherapy

Gene Transfer

6.2. Global Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Large B-Cell Lymphoma

Multiple Myeloma

Acute Lymphoblastic Leukemia (ALL)

Melanoma

Other Indications

6.3. Global Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lentivirus

RetroVirus And Gamma RetroVirus

Adeno-Associated Virus (AAV)

Modified Herpes Simplex Virus

Adenovirus

Other Vector Types

6.4. Global Cancer Gene Therapy Market, Segmentation By End-User , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Research Institutes

Biopharma Companies

Diagnostic Centers

Other End Users

6.5. Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Induced Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

CAR-T Cell Therapy

TCR (T-Cell Receptor) Therapy

Tumor-Infiltrating Lymphocyte (TIL) Therapy

Dendritic Cell-Based Gene Therapy

NK Cell Gene Therapy

6.6. Global Cancer Gene Therapy Market, Sub-Segmentation Of Oncolytic Virotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adenoviruses

Herpes Simplex Virus (HSV)

Reovirus

Vaccinia Virus

Newcastle Disease Virus (NDV)

6.7. Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Transfer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Viral Gene Transfer

Non-Viral Gene Transfer

7. Cancer Gene Therapy Market Regional And Country Analysis

7.1. Global Cancer Gene Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cancer Gene Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Gene Therapy Market

8.1. Asia-Pacific Cancer Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Gene Therapy Market

9.1. China Cancer Gene Therapy Market Overview

9.2. China Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Gene Therapy Market

10.1. India Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Gene Therapy Market

11.1. Japan Cancer Gene Therapy Market Overview

11.2. Japan Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Gene Therapy Market

12.1. Australia Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Gene Therapy Market

13.1. Indonesia Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Gene Therapy Market

14.1. South Korea Cancer Gene Therapy Market Overview

14.2. South Korea Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Gene Therapy Market

15.1. Western Europe Cancer Gene Therapy Market Overview

15.2. Western Europe Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Gene Therapy Market

16.1. UK Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Gene Therapy Market

17.1. Germany Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Gene Therapy Market

18.1. France Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Gene Therapy Market

19.1. Italy Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Gene Therapy Market

20.1. Spain Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Gene Therapy Market

21.1. Eastern Europe Cancer Gene Therapy Market Overview

21.2. Eastern Europe Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Gene Therapy Market

22.1. Russia Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Gene Therapy Market

23.1. North America Cancer Gene Therapy Market Overview

23.2. North America Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Gene Therapy Market

24.1. USA Cancer Gene Therapy Market Overview

24.2. USA Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Gene Therapy Market

25.1. Canada Cancer Gene Therapy Market Overview

25.2. Canada Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Gene Therapy Market

26.1. South America Cancer Gene Therapy Market Overview

26.2. South America Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Gene Therapy Market

27.1. Brazil Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Gene Therapy Market

28.1. Middle East Cancer Gene Therapy Market Overview

28.2. Middle East Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Gene Therapy Market

29.1. Africa Cancer Gene Therapy Market Overview

29.2. Africa Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Gene Therapy Market Competitive Landscape And Company Profiles

30.1. Cancer Gene Therapy Market Competitive Landscape

30.2. Cancer Gene Therapy Market Company Profiles

30.2.1. Bristol Myers Company Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. GSK plc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Gene Therapy Market Other Major And Innovative Companies

31.1. Orchard Therapeutics Plc

31.2. Biogen Inc.

31.3. Sarepta Therapeutics Inc.

31.4. AGC Biologics

31.5. Adaptimmune Limited

31.6. Sibiono

31.7. Elevate Bio Inc.

31.8. Bluebird Bio Inc.

31.9. Uniqure N.V.

31.10. Shanghai Sunway Biotech Co. Ltd.

31.11. Anges Inc.

31.12. Gensight Biologics

31.13. Genelux Corporation

31.14. Cellectis

31.15. Abeona Therapeutics Inc.

32. Global Cancer Gene Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Gene Therapy Market

34. Recent Developments In The Cancer Gene Therapy Market

35. Cancer Gene Therapy Market High Potential Countries, Segments and Strategies

35.1 Cancer Gene Therapy Market In 2029 - Countries Offering Most New Opportunities

35.2 Cancer Gene Therapy Market In 2029 - Segments Offering Most New Opportunities

35.3 Cancer Gene Therapy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Cancer Gene Therapy Market, Segmentation By End-User , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Induced Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Cancer Gene Therapy Market, Sub-Segmentation Of Oncolytic Virotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Transfer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Cancer Gene Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Cancer Gene Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Bristol Myers Company Financial Performance

Table 79: Novartis AG Financial Performance

Table 80: GSK plc. Financial Performance

Table 81: Gilead Sciences Inc. Financial Performance

Table 82: Amgen Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Cancer Gene Therapy Market, Segmentation By End-User , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Induced Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Cancer Gene Therapy Market, Sub-Segmentation Of Oncolytic Virotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Transfer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Cancer Gene Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Cancer Gene Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Bristol Myers Company Financial Performance

Figure 79: Novartis AG Financial Performance

Figure 80: GSK plc. Financial Performance

Figure 81: Gilead Sciences Inc. Financial Performance

Figure 82: Amgen Inc. Financial Performance

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Understanding Key Drivers and Growth Opportunities in the Medical Automation Technologies Market: Trends and Market Size Insights

Medical Billing Software Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034

Medical Device Contract Research Organization Market Growth Outlook: Trends, Market Size, and Opportunities Over the Next Decade

Key Insights into the Medical Device Cybersecurity Solutions Market: Trends, Growth Rate, and Opportunities Through 2034

Commercial Fan And Air Purification Equipment Market - By Type (Air Purification Equipment, Attic And Exhaust Fan), By Range (Less Than 200 Square Ft, 200 - 400 Square Ft, More Than 400 Square Ft), And By Region, Opportunities And Strategies - Global Forecast To 2030

View Report

Commercial Fan And Air Purification Equipment Market - By Type (Air Purification Equipment, Attic And Exhaust Fan), By Range (Less Than 200 Square Ft, 200 - 400 Square Ft, More Than 400 Square Ft), And By Region, Opportunities And Strategies - Global Forecast To 2030

View Report

Satellite Propulsion System Global Market Report 2025 – By Type (Chemical Propulsion, Electric Propulsion, Hybrid Propulsion, Other Types), By Orbit (Low Earth Orbit (LEO), Medium Earth Orbit (MEO), Geostationary Earth Orbit (GEO), Beyond Geosynchronous Orbit), By Application (Commercial Use, Science And Environment, National Security And Military, Meteorology, Other Applications ) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Household Type Fans Global Market Report 2025 – By Type Of Product (Ceiling Fans, Table, Pedestal and Wall Fans, Exhaust Fans And Others), By Type of Current (AC Residential Fans, DC Residential Fans), By Application (Home, Commercial), By Distribution Channel (Store-based Retailing, Direct Sales, Non Store based Retailing) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Roofing Underlayment Global Market Report 2025 – By Product (Asphalt-Saturated Felt, Rubberized Asphalt, Non-Bitumen Synthetic), By Installation Method (Self-Adhesive, Mechanically Attached), By Barrier Property (Water-Resistant, Waterproof), By Application (Residential Construction, Commercial, Non-Residential Construction) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

HVAC And Commercial And Industrial Refrigeration Equipment Global Market Report 2025 – By Type (HVAC Equipment, Commercial And Industrial Refrigeration Equipment), By Capacity (Small, Medium, Large), By Application (Food Processing, Beverage Production, Chemicals and Pharmaceuticals, Petrochemicals, Energy, Logistics) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Frequently Asked Questions

What is the definition of the Cancer Gene Therapy market?

How will the Cancer Gene Therapy market drivers and restraints affect the market dynamics? What forces will shape the Cancer Gene Therapy industry going forward?

The market major growth driver - Rising Cancer Incidence Fueling The Growth Of The Market Due To Increasing Life Expectancy. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Cancer Gene Therapy market?

The cancer gene therapy market size has grown rapidly in recent years. It will grow from $3.61 billion in 2024 to $4.21 billion in 2025 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to growing awareness of oncovirus-related cancers, rising collaborations between biotech firms and academic institutions, increasing clinical trial activity in early-phase gene therapies, growing demand for ex vivo modified cell therapies, and a surge in strategic licensing agreements for gene therapy platforms. The cancer gene therapy market size is expected to see rapid growth in the next few years. It will grow to $7.67 billion in 2029 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to rising focus on non-viral delivery systems, increasing availability of companion diagnostics, growing interest in off-the-shelf allogeneic cell therapies, rising expansion of contract development & manufacturing organizations (CDMOs), and advancing synthetic biology enabling customizable gene circuits. Major trends in the forecast period include advancement in non-viral gene delivery platforms, advanced manufacturing automation for gene therapy production, development of synthetic promoters for cancer-specific expression, innovation in intratumoral gene therapy administration, and development of multiplexed gene modulation strategies. For further insights on this market, request a sample here

How is the Cancer Gene Therapy market segmented?

The cancer gene therapy market covered in this report is segmented
1) By Therapy: Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer
2) By Indication: Large B-Cell Lymphoma, Multiple Myeloma, Acute Lymphoblastic Leukemia (ALL), Melanoma (lesions), Other Indications
3) By Vector Type: Lentivirus, RetroVirus And Gamma RetroVirus, Adeno-Associated Virus (AAV), Modified Herpes Simplex Virus, Adenovirus, Other Vector Types
4) By End-User: Hospitals, Research Institutes, Biopharma Companies, Diagnostic centers, Other End Users Subsegments:
1) By Gene Induced Immunotherapy: CAR-T Cell Therapy, TCR (T-Cell Receptor) Therapy, Tumor-Infiltrating Lymphocyte (TIL) Therapy, Dendritic Cell-Based Gene Therapy, NK Cell Gene Therapy
2) By Oncolytic Virotherapy: Adenoviruses, Herpes Simplex Virus (HSV), Reovirus, Vaccinia Virus, Newcastle Disease Virus (NDV)
3) By Gene Transfer: Viral Gene Transfer, Non-Viral Gene Transfer For further insights on this market, request a sample here

Which region has the largest share of the Cancer Gene Therapy market? What are the other regions covered in the report?

North America was the largest region in the cancer gene therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Cancer Gene Therapy market?

What are the key trends in the Cancer Gene Therapy market?

Major trends in this market include Breakthrough In Affordable Personalized Cancer Treatment Through Advanced Cell Therapy. For further insights on this market, request a sample here.

Cancer Gene Therapy Global Market Report 2025

Cancer Gene Therapy Global Market Report 2025

Market Insights

Related Reports

Cancer Gene Therapy Market Overview

What Is Covered Under Cancer Gene Therapy Market?

What Is The Cancer Gene Therapy Market Size 2025 And Growth Rate?

What Is The Cancer Gene Therapy Market Growth Forecast?

What’s The Trade War Impact On Healthcare Services Industry?

How Is The Cancer Gene Therapy Market Segmented?

What Is Driving The Cancer Gene Therapy Market? Rising Cancer Incidence Fueling The Growth Of The Market Due To Increasing Life Expectancy

Who Are The Major Players In The Global Cancer Gene Therapy Market?

What Are The Key Trends Of The Global Cancer Gene Therapy Market? Breakthrough In Affordable Personalized Cancer Treatment Through Advanced Cell Therapy

What Are Latest Mergers And Acquisitions In The Cancer Gene Therapy Market? Astrazeneca Acquires Esobiotec To Bolster Cell Therapy Pipeline

What Is The Regional Outlook For The Global Cancer Gene Therapy Market?

What Defines the Cancer Gene Therapy Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Cancer Gene Therapy Industry?

Table Of Contents

List Of Tables

List Of Figures

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Understanding Key Drivers and Growth Opportunities in the Medical Automation Technologies Market: Trends and Market Size Insights

Medical Billing Software Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034

Medical Device Contract Research Organization Market Growth Outlook: Trends, Market Size, and Opportunities Over the Next Decade

Key Insights into the Medical Device Cybersecurity Solutions Market: Trends, Growth Rate, and Opportunities Through 2034

Commercial Fan And Air Purification Equipment Market - By Type (Air Purification Equipment, Attic And Exhaust Fan), By Range (Less Than 200 Square Ft, 200 - 400 Square Ft, More Than 400 Square Ft), And By Region, Opportunities And Strategies - Global Forecast To 2030

Commercial Fan And Air Purification Equipment Market - By Type (Air Purification Equipment, Attic And Exhaust Fan), By Range (Less Than 200 Square Ft, 200 - 400 Square Ft, More Than 400 Square Ft), And By Region, Opportunities And Strategies - Global Forecast To 2030

Frequently Asked Questions